Literature DB >> 26143088

[Evaluation of the metrological quality of the medico-administrative data for perinatal indicators: A pilot study in 3 university hospitals].

A Pierron1, M Revert2, K Goueslard3, A Vuagnat4, J Cottenet1, E Benzenine1, J Fresson5, C Quantin6.   

Abstract

BACKGROUND: In order to assess public health policies for the perinatal period, routinely produced indicators are needed for the whole population. In France, these indicators are used to compare the national public health policy with those of other European countries. French administrative and medical data (PMSI) are straightforward and reliable and may be a valuable source of information for research. This study aimed to measure the quality of PMSI data from three university health centers for core indicators in perinatal health.
METHOD: PMSI data were compared with medical files in 2012 from 300 live births after 22 weeks of amenorrhea, drawn at random from University Hospitals in Dijon, Paris and Nancy. The variables were chosen based on the Europeristat Project's core and recommended indicators, as well as those of the French National Perinatal survey conducted in 2010. The information gathered blindly from the medical files was compared with the PMSI data positive predictive value (PPV) and the sensitivity was used to assess data quality.
RESULTS: Data on maternal age, parity and mode of delivery as well as the rates of premature births were superimposable for the two sources. The PPV for epidural injection was 96.2% and 94.3% for perineal tears. Overall, maternal morbidity was underdocumented in the PMSI, so the PPV was 100.0% for pre-existing diabetes, 88.9% for gestational diabetes and 100.0% for high blood pressure with a rate of 9.0% in PMSI and 6.3% in the medical files. The PPV for bleeding during labor was 89.5%.
CONCLUSION: To conclude, PMSI data are apparently becoming more and more reliable for two reasons: on one hand, the importance of these data for budgetary promotion in hospitals; on the other, the increasing use of this information for statistical and epidemiological purposes.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Base de données hospitalières; Indicateurs d’état de santé; Morbidité maternelle; PMSI; Perinatal health; Perinatal indicators; Positive predicitve value; Sensibilité; Sensitivity; Valeur prédictive positive; Validation

Mesh:

Year:  2015        PMID: 26143088     DOI: 10.1016/j.respe.2015.05.001

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  11 in total

1.  Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012.

Authors:  Cécile Billionnet; Delphine Mitanchez; Alain Weill; Jacky Nizard; François Alla; Agnès Hartemann; Sophie Jacqueminet
Journal:  Diabetologia       Date:  2017-02-15       Impact factor: 10.122

2.  A novel classification for evaluating episiotomy practices: application to the Burgundy perinatal network.

Authors:  Thomas Desplanches; Emilie Szczepanski; Jonathan Cottenet; Denis Semama; Catherine Quantin; Paul Sagot
Journal:  BMC Pregnancy Childbirth       Date:  2019-08-16       Impact factor: 3.007

3.  A systematic review of database validation studies among fertility populations.

Authors:  V Bacal; M Russo; D B Fell; H Shapiro; M Walker; L M Gaudet
Journal:  Hum Reprod Open       Date:  2019-06-06

4.  Increased Risk of Hospitalization for Pancreatic Cancer in the First 8 Years after a Gestational Diabetes Mellitus regardless of Subsequent Type 2 Diabetes: A Nationwide Population-Based Study.

Authors:  Julien Simon; Karine Goueslard; Patrick Arveux; Sonia Bechraoui-Quantin; Jean-Michel Petit; Catherine Quantin
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

5.  Early cardiovascular events in women with a history of gestational diabetes mellitus.

Authors:  Karine Goueslard; Jonathan Cottenet; Anne-Sophie Mariet; Maurice Giroud; Yves Cottin; Jean-Michel Petit; Catherine Quantin
Journal:  Cardiovasc Diabetol       Date:  2016-01-27       Impact factor: 9.951

6.  Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.

Authors:  Pierre-Olivier Blotière; Alain Weill; Marie Dalichampt; Cécile Billionnet; Myriam Mezzarobba; Fanny Raguideau; Rosemary Dray-Spira; Mahmoud Zureik; Joël Coste; François Alla
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-05-15       Impact factor: 2.890

7.  Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database.

Authors:  Eve-Marie Thillard; Sophie Gautier; Evgeniya Babykina; Louise Carton; Ali Amad; Guillaume Bouzillé; Jean-Baptiste Beuscart; Grégoire Ficheur; Emmanuel Chazard
Journal:  Front Pharmacol       Date:  2020-04-22       Impact factor: 5.810

8.  Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013).

Authors:  Brigitte Fauroux; Jean-Michel Hascoët; Pierre-Henri Jarreau; Jean-François Magny; Jean-Christophe Rozé; Elie Saliba; Michaël Schwarzinger
Journal:  PLoS One       Date:  2020-03-06       Impact factor: 3.240

9.  Episiotomy practices in France: epidemiology and risk factors in non-operative vaginal deliveries.

Authors:  Christophe Clesse; Jonathan Cottenet; Joelle Lighezzolo-Alnot; Karine Goueslard; Michele Scheffler; Paul Sagot; Catherine Quantin
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

10.  Prevalence of hypertensive disorders during pregnancy in France (2010-2018): The Nationwide CONCEPTION Study.

Authors:  Valérie Olié; Elodie Moutengou; Clémence Grave; Catherine Deneux-Tharaux; Nolwenn Regnault; Sandrine Kretz; Amélie Gabet; Claire Mounier-Vehier; Vassilis Tsatsaris; Geneviève Plu-Bureau; Jacques Blacher
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.